Treatment and Prognosis of Hematological Malignancies

Dear Colleagues,

During the last two decades, we have witnessed a complete transformation in how we approach hematological diseases. A deeper understanding of the biology of specific hematological malignancies has exposed numerous novel therapeutic agents.

Monoclonal antibodies, bispecific T cell engagers, antibody–drug conjugates, as well as immunotoxins are increasingly used for cancer immunotherapy. Cellular immunotherapeutic agents, including the chimeric antigen receptor-engineered T cell (CAR-T) therapy and NK cell therapy, have fundamentally changed the landscape of hematological malignancies therapy from cytotoxic chemotherapy to biomarker-driven precision agents.  In this Special Issue, “Treatment and Prognosis of Hematological Malignancies”, experts discuss recent innovations in this field and lay out the remaining key questions for the near future.

Dr. Magdalena Witkowska
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Hematology Reports is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.